BG107282A - Метод и състав на ваксина за орален прием - Google Patents

Метод и състав на ваксина за орален прием Download PDF

Info

Publication number: BG107282A
Authority: BG; Bulgaria
Prior art keywords: vaccine; virus; canine; animal; feline
Prior art date: 2000-06-30

Application number

BG107282A

Other languages

Bulgarian (bg)

English (en)

Inventor

Hsien-Jue CHU (Steve)

Wumin Li

Original Assignee

Wyeth

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-30

Filing date

2002-11-18

Publication date

2003-06-30

2002-11-18 Application filed by Wyeth filed Critical Wyeth

2003-06-30 Publication of BG107282A publication Critical patent/BG107282A/bg

Links

239000000203 mixture Substances 0.000 title claims abstract description 68
238000002255 vaccination Methods 0.000 title abstract description 81
238000000034 method Methods 0.000 title abstract description 35
229960005486 vaccine Drugs 0.000 claims abstract description 159
241001465754 Metazoa Species 0.000 claims abstract description 95
208000015181 infectious disease Diseases 0.000 claims abstract description 80
239000000427 antigen Substances 0.000 claims abstract description 51
108091007433 antigens Proteins 0.000 claims abstract description 51
102000036639 antigens Human genes 0.000 claims abstract description 51
235000020357 syrup Nutrition 0.000 claims abstract description 39
239000006188 syrup Substances 0.000 claims abstract description 39
239000003651 drinking water Substances 0.000 claims abstract description 35
235000020188 drinking water Nutrition 0.000 claims abstract description 35
201000010099 disease Diseases 0.000 claims abstract description 23
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 23
241000282887 Suidae Species 0.000 claims description 105
241000282898 Sus scrofa Species 0.000 claims description 46
238000009472 formulation Methods 0.000 claims description 38
241000186810 Erysipelothrix rhusiopathiae Species 0.000 claims description 29
241000700605 Viruses Species 0.000 claims description 25
241000282465 Canis Species 0.000 claims description 23
230000002458 infectious effect Effects 0.000 claims description 23
241000283690 Bos taurus Species 0.000 claims description 20
229940126578 oral vaccine Drugs 0.000 claims description 20
241000271566 Aves Species 0.000 claims description 19
241000282472 Canis lupus familiaris Species 0.000 claims description 15
241000282324 Felis Species 0.000 claims description 15
241000282326 Felis catus Species 0.000 claims description 15
241000589902 Leptospira Species 0.000 claims description 15
238000002156 mixing Methods 0.000 claims description 14
241000894006 Bacteria Species 0.000 claims description 11
241001494479 Pecora Species 0.000 claims description 11
241000283086 Equidae Species 0.000 claims description 10
241000283707 Capra Species 0.000 claims description 9
241000283073 Equus caballus Species 0.000 claims description 8
206010037742 Rabies Diseases 0.000 claims description 8
241000712461 unidentified influenza virus Species 0.000 claims description 8
230000001965 increasing effect Effects 0.000 claims description 7
241000588724 Escherichia coli Species 0.000 claims description 6
208000002606 Paramyxoviridae Infections Diseases 0.000 claims description 6
239000004480 active ingredient Substances 0.000 claims description 6
241000193403 Clostridium Species 0.000 claims description 5
241001550390 Leptospira interrogans serovar Canicola Species 0.000 claims description 5
241001518154 Leptospira kirschneri serovar Grippotyphosa Species 0.000 claims description 5
241000711493 Porcine respiratory coronavirus Species 0.000 claims description 5
206010051497 Rhinotracheitis Diseases 0.000 claims description 5
241000606750 Actinobacillus Species 0.000 claims description 4
241000588779 Bordetella bronchiseptica Species 0.000 claims description 4
208000027312 Bursal disease Diseases 0.000 claims description 4
241000711506 Canine coronavirus Species 0.000 claims description 4
241000701931 Canine parvovirus Species 0.000 claims description 4
241001647378 Chlamydia psittaci Species 0.000 claims description 4
241001533384 Circovirus Species 0.000 claims description 4
208000006825 Eastern Equine Encephalomyelitis Diseases 0.000 claims description 4
201000005804 Eastern equine encephalitis Diseases 0.000 claims description 4
241000605312 Ehrlichia canis Species 0.000 claims description 4
241000702680 Equine rotavirus Species 0.000 claims description 4
208000002613 Feline Panleukopenia Diseases 0.000 claims description 4
241000701047 Gallid alphaherpesvirus 2 Species 0.000 claims description 4
241000589926 Leptospira interrogans serovar Hardjo Species 0.000 claims description 4
241000204031 Mycoplasma Species 0.000 claims description 4
208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 claims description 4
241000702670 Rotavirus Species 0.000 claims description 4
241000607142 Salmonella Species 0.000 claims description 4
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 claims description 4
208000002687 Venezuelan Equine Encephalomyelitis Diseases 0.000 claims description 4
208000005466 Western Equine Encephalomyelitis Diseases 0.000 claims description 4
201000005806 Western equine encephalitis Diseases 0.000 claims description 4
206010006451 bronchitis Diseases 0.000 claims description 4
229940051998 ehrlichia canis Drugs 0.000 claims description 4
241000711404 Avian avulavirus 1 Species 0.000 claims description 3
241000702673 Bovine rotavirus Species 0.000 claims description 3
241000701157 Canine mastadenovirus A Species 0.000 claims description 3
208000000655 Distemper Diseases 0.000 claims description 3
241000713800 Feline immunodeficiency virus Species 0.000 claims description 3
241000714165 Feline leukemia virus Species 0.000 claims description 3
208000010359 Newcastle Disease Diseases 0.000 claims description 3
241000125945 Protoparvovirus Species 0.000 claims description 3
241000702263 Reovirus sp. Species 0.000 claims description 3
241000392514 Salmonella enterica subsp. enterica serovar Dublin Species 0.000 claims description 3
208000014058 canine distemper Diseases 0.000 claims description 3
235000019264 food flavour enhancer Nutrition 0.000 claims description 3
241000588807 Bordetella Species 0.000 claims description 2
241000711443 Bovine coronavirus Species 0.000 claims description 2
241000193449 Clostridium tetani Species 0.000 claims description 2
206010012735 Diarrhoea Diseases 0.000 claims description 2
241000286209 Phasianidae Species 0.000 claims description 2
241000725643 Respiratory syncytial virus Species 0.000 claims description 2
241000194048 Streptococcus equi Species 0.000 claims description 2
230000001939 inductive effect Effects 0.000 claims description 2
241000589969 Borreliella burgdorferi Species 0.000 claims 2
241000711475 Feline infectious peritonitis virus Species 0.000 claims 2
241000224467 Giardia intestinalis Species 0.000 claims 2
208000003217 Tetany Diseases 0.000 claims 2
229940085435 giardia lamblia Drugs 0.000 claims 2
241000711573 Coronaviridae Species 0.000 claims 1
241000283087 Equus Species 0.000 claims 1
241001646719 Escherichia coli O157:H7 Species 0.000 claims 1
230000001580 bacterial effect Effects 0.000 abstract description 19
230000003612 virological effect Effects 0.000 abstract description 16
239000000796 flavoring agent Substances 0.000 abstract description 12
235000019634 flavors Nutrition 0.000 abstract description 11
230000008569 process Effects 0.000 abstract description 4
239000003814 drug Substances 0.000 abstract description 3
230000006806 disease prevention Effects 0.000 abstract description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 56
239000011550 stock solution Substances 0.000 description 31
208000024891 symptom Diseases 0.000 description 25
239000000463 material Substances 0.000 description 15
238000002360 preparation method Methods 0.000 description 15
201000000297 Erysipelas Diseases 0.000 description 13
230000037396 body weight Effects 0.000 description 12
241000186811 Erysipelothrix Species 0.000 description 7
238000004364 calculation method Methods 0.000 description 6
239000003795 chemical substances by application Substances 0.000 description 6
238000002347 injection Methods 0.000 description 6
239000007924 injection Substances 0.000 description 6
235000013372 meat Nutrition 0.000 description 6
210000004369 blood Anatomy 0.000 description 5
239000008280 blood Substances 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
238000011887 Necropsy Methods 0.000 description 4
206010037660 Pyrexia Diseases 0.000 description 4
239000003637 basic solution Substances 0.000 description 4
230000008901 benefit Effects 0.000 description 4
238000010790 dilution Methods 0.000 description 4
239000012895 dilution Substances 0.000 description 4
244000144980 herd Species 0.000 description 4
238000003359 percent control normalization Methods 0.000 description 4
235000020183 skimmed milk Nutrition 0.000 description 4
206010040882 skin lesion Diseases 0.000 description 4
231100000444 skin lesion Toxicity 0.000 description 4
238000010561 standard procedure Methods 0.000 description 4
238000003756 stirring Methods 0.000 description 4
230000035899 viability Effects 0.000 description 4
241000272517 Anseriformes Species 0.000 description 3
241000287828 Gallus gallus Species 0.000 description 3
239000003708 ampul Substances 0.000 description 3
206010003246 arthritis Diseases 0.000 description 3
239000006161 blood agar Substances 0.000 description 3
210000004027 cell Anatomy 0.000 description 3
235000013330 chicken meat Nutrition 0.000 description 3
238000011109 contamination Methods 0.000 description 3
239000003085 diluting agent Substances 0.000 description 3
239000011859 microparticle Substances 0.000 description 3
244000144977 poultry Species 0.000 description 3
235000013594 poultry meat Nutrition 0.000 description 3
239000000843 powder Substances 0.000 description 3
241000272525 Anas platyrhynchos Species 0.000 description 2
208000031295 Animal disease Diseases 0.000 description 2
208000035473 Communicable disease Diseases 0.000 description 2
206010011906 Death Diseases 0.000 description 2
235000016623 Fragaria vesca Nutrition 0.000 description 2
240000009088 Fragaria x ananassa Species 0.000 description 2
235000011363 Fragaria x ananassa Nutrition 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
206010024264 Lethargy Diseases 0.000 description 2
LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 2
101000775071 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Peroxiredoxin AHP1 Proteins 0.000 description 2
229920002472 Starch Polymers 0.000 description 2
206010042434 Sudden death Diseases 0.000 description 2
102000001400 Tryptase Human genes 0.000 description 2
108060005989 Tryptase Proteins 0.000 description 2
239000002671 adjuvant Substances 0.000 description 2
230000002238 attenuated effect Effects 0.000 description 2
230000005540 biological transmission Effects 0.000 description 2
150000001720 carbohydrates Chemical class 0.000 description 2
235000014633 carbohydrates Nutrition 0.000 description 2
238000012217 deletion Methods 0.000 description 2
230000037430 deletion Effects 0.000 description 2
229910003460 diamond Inorganic materials 0.000 description 2
239000010432 diamond Substances 0.000 description 2
230000035622 drinking Effects 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000000975 dye Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
239000003623 enhancer Substances 0.000 description 2
244000144992 flock Species 0.000 description 2
235000013305 food Nutrition 0.000 description 2
239000008369 fruit flavor Substances 0.000 description 2
244000144993 groups of animals Species 0.000 description 2
230000036541 health Effects 0.000 description 2
230000002163 immunogen Effects 0.000 description 2
230000000415 inactivating effect Effects 0.000 description 2
238000011081 inoculation Methods 0.000 description 2
238000003780 insertion Methods 0.000 description 2
230000037431 insertion Effects 0.000 description 2
231100000636 lethal dose Toxicity 0.000 description 2
239000007788 liquid Substances 0.000 description 2
235000013336 milk Nutrition 0.000 description 2
239000008267 milk Substances 0.000 description 2
210000004080 milk Anatomy 0.000 description 2
238000012544 monitoring process Methods 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
230000001717 pathogenic effect Effects 0.000 description 2
230000001681 protective effect Effects 0.000 description 2
230000000405 serological effect Effects 0.000 description 2
239000000243 solution Substances 0.000 description 2
235000019698 starch Nutrition 0.000 description 2
239000008107 starch Substances 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
238000012360 testing method Methods 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
241000251468 Actinopterygii Species 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
108010065511 Amylases Proteins 0.000 description 1
102000013142 Amylases Human genes 0.000 description 1
241001600407 Aphis <genus> Species 0.000 description 1
241000167854 Bourreria succulenta Species 0.000 description 1
235000001258 Cinchona calisaya Nutrition 0.000 description 1
244000241235 Citrullus lanatus Species 0.000 description 1
235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
206010010774 Constipation Diseases 0.000 description 1
229920002261 Corn starch Polymers 0.000 description 1
206010011224 Cough Diseases 0.000 description 1
206010011703 Cyanosis Diseases 0.000 description 1
108020004414 DNA Proteins 0.000 description 1
229930091371 Fructose Natural products 0.000 description 1
239000005715 Fructose Substances 0.000 description 1
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
208000005577 Gastroenteritis Diseases 0.000 description 1
206010064571 Gene mutation Diseases 0.000 description 1
241000224466 Giardia Species 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
GVGLGOZIDCSQPN-PVHGPHFFSA-N Heroin Chemical compound O([C@H]1[C@H](C=C[C@H]23)OC(C)=O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4OC(C)=O GVGLGOZIDCSQPN-PVHGPHFFSA-N 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 description 1
206010061217 Infestation Diseases 0.000 description 1
206010022095 Injection Site reaction Diseases 0.000 description 1
206010022061 Injection site erythema Diseases 0.000 description 1
MKXZASYAUGDDCJ-SZMVWBNQSA-N LSM-2525 Chemical compound C1CCC[C@H]2[C@@]3([H])N(C)CC[C@]21C1=CC(OC)=CC=C1C3 MKXZASYAUGDDCJ-SZMVWBNQSA-N 0.000 description 1
241000220225 Malus Species 0.000 description 1
235000011430 Malus pumila Nutrition 0.000 description 1
235000015103 Malus silvestris Nutrition 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
235000014676 Phragmites communis Nutrition 0.000 description 1
206010037867 Rash macular Diseases 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
CZMRCDWAGMRECN-UHFFFAOYSA-N Rohrzucker Natural products OCC1OC(CO)(OC2OC(CO)C(O)C(O)C2O)C(O)C1O CZMRCDWAGMRECN-UHFFFAOYSA-N 0.000 description 1
206010040047 Sepsis Diseases 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
206010043376 Tetanus Diseases 0.000 description 1
HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
235000009754 Vitis X bourquina Nutrition 0.000 description 1
235000012333 Vitis X labruscana Nutrition 0.000 description 1
240000006365 Vitis vinifera Species 0.000 description 1
235000014787 Vitis vinifera Nutrition 0.000 description 1
206010052428 Wound Diseases 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
238000013019 agitation Methods 0.000 description 1
HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
235000019418 amylase Nutrition 0.000 description 1
229940025131 amylases Drugs 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
238000010171 animal model Methods 0.000 description 1
208000022531 anorexia Diseases 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
239000003434 antitussive agent Substances 0.000 description 1
229940124584 antitussives Drugs 0.000 description 1
230000036528 appetite Effects 0.000 description 1
235000019789 appetite Nutrition 0.000 description 1
238000003556 assay Methods 0.000 description 1
244000052616 bacterial pathogen Species 0.000 description 1
239000001045 blue dye Substances 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
244000309464 bull Species 0.000 description 1
244000309466 calf Species 0.000 description 1
DASYMCLQENWCJG-XUKDPADISA-N cefetamet pivoxil Chemical compound N([C@@H]1C(N2C(=C(C)CS[C@@H]21)C(=O)OCOC(=O)C(C)(C)C)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 DASYMCLQENWCJG-XUKDPADISA-N 0.000 description 1
229950000726 cefetamet pivoxil Drugs 0.000 description 1
LTINZAODLRIQIX-FBXRGJNPSA-N cefpodoxime proxetil Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC)C(=O)OC(C)OC(=O)OC(C)C)C(=O)C(=N/OC)\C1=CSC(N)=N1 LTINZAODLRIQIX-FBXRGJNPSA-N 0.000 description 1
229960004797 cefpodoxime proxetil Drugs 0.000 description 1
235000013339 cereals Nutrition 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
238000002512 chemotherapy Methods 0.000 description 1
235000019693 cherries Nutrition 0.000 description 1
LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 1
230000001332 colony forming effect Effects 0.000 description 1
235000008504 concentrate Nutrition 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
235000009508 confectionery Nutrition 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
229940028617 conventional vaccine Drugs 0.000 description 1
239000008120 corn starch Substances 0.000 description 1
238000002425 crystallisation Methods 0.000 description 1
230000008025 crystallization Effects 0.000 description 1
230000000120 cytopathologic effect Effects 0.000 description 1
235000013365 dairy product Nutrition 0.000 description 1
206010061428 decreased appetite Diseases 0.000 description 1
230000001687 destabilization Effects 0.000 description 1
229960001985 dextromethorphan Drugs 0.000 description 1
206010012601 diabetes mellitus Diseases 0.000 description 1
229960002069 diamorphine Drugs 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
208000002173 dizziness Diseases 0.000 description 1
210000005069 ears Anatomy 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
239000006260 foam Substances 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
239000008103 glucose Substances 0.000 description 1
230000003862 health status Effects 0.000 description 1
208000021760 high fever Diseases 0.000 description 1
102000044162 human IGF1 Human genes 0.000 description 1
230000028993 immune response Effects 0.000 description 1
238000010166 immunofluorescence Methods 0.000 description 1
230000016784 immunoglobulin production Effects 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
239000002054 inoculum Substances 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
238000002955 isolation Methods 0.000 description 1
JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
229960000511 lactulose Drugs 0.000 description 1
PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
238000009630 liquid culture Methods 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
210000001165 lymph node Anatomy 0.000 description 1
239000012931 lyophilized formulation Substances 0.000 description 1
206010025482 malaise Diseases 0.000 description 1
201000004792 malaria Diseases 0.000 description 1
239000000845 maltitol Substances 0.000 description 1
235000010449 maltitol Nutrition 0.000 description 1
VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
229940035436 maltitol Drugs 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
230000008774 maternal effect Effects 0.000 description 1
239000002609 medium Substances 0.000 description 1
239000000155 melt Substances 0.000 description 1
229960001797 methadone Drugs 0.000 description 1
238000001471 micro-filtration Methods 0.000 description 1
230000000813 microbial effect Effects 0.000 description 1
238000007431 microscopic evaluation Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
210000004237 neck muscle Anatomy 0.000 description 1
239000002773 nucleotide Substances 0.000 description 1
125000003729 nucleotide group Chemical group 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
239000002245 particle Substances 0.000 description 1
238000009304 pastoral farming Methods 0.000 description 1
244000052769 pathogen Species 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
238000011170 pharmaceutical development Methods 0.000 description 1
DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
229960002695 phenobarbital Drugs 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
208000009305 pseudorabies Diseases 0.000 description 1
229960000948 quinine Drugs 0.000 description 1
238000005070 sampling Methods 0.000 description 1
208000013223 septicemia Diseases 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 description 1
239000002904 solvent Substances 0.000 description 1
238000002798 spectrophotometry method Methods 0.000 description 1
210000000952 spleen Anatomy 0.000 description 1
239000007921 spray Substances 0.000 description 1
238000005507 spraying Methods 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
238000010186 staining Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
239000007916 tablet composition Substances 0.000 description 1
238000010257 thawing Methods 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
210000002105 tongue Anatomy 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
238000010200 validation analysis Methods 0.000 description 1
229940102566 valproate Drugs 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
244000052613 viral pathogen Species 0.000 description 1
230000004580 weight loss Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Immunology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Mycology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Virology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Fodder In General (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

BG107282A 2000-06-30 2002-11-18 Метод и състав на ваксина за орален прием BG107282A (bg)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US21535900P	2000-06-30	2000-06-30
PCT/US2001/020155 WO2002002139A2 (fr)	2000-06-30	2001-06-22	Methodes et composition destinees a une vaccination par voie orale

Publications (1)

Publication Number	Publication Date
BG107282A true BG107282A (bg)	2003-06-30

Family

ID=22802674

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG107282A BG107282A (bg)	2000-06-30	2002-11-18	Метод и състав на ваксина за орален прием

Country Status (18)

Country	Link
US (2)	US20020025325A1 (fr)
EP (1)	EP1294399A2 (fr)
JP (1)	JP2004501979A (fr)
KR (1)	KR20030013480A (fr)
CN (1)	CN100457179C (fr)
AR (1)	AR030702A1 (fr)
AU (2)	AU7013501A (fr)
BG (1)	BG107282A (fr)
BR (1)	BR0111916A (fr)
CZ (1)	CZ20024222A3 (fr)
HU (1)	HUP0301394A3 (fr)
MX (1)	MXPA02012201A (fr)
MY (1)	MY128159A (fr)
NZ (1)	NZ523329A (fr)
PL (1)	PL360026A1 (fr)
WO (1)	WO2002002139A2 (fr)
YU (1)	YU99102A (fr)
ZA (1)	ZA200210402B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7923023B2 (en) *	2002-02-25	2011-04-12	Astech International LLC	Method and composition for delivery of medicants to animals
US8519008B2 (en)	2003-01-22	2013-08-27	Purina Animal Nutrition Llc	Method and composition for improving the health of young monogastric mammals
US8637047B2 (en) *	2003-10-30	2014-01-28	Boehringer Ingelheim Vetmedica, Inc.	Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
US20050158367A1 (en) *	2004-01-16	2005-07-21	The Procter & Gamble Company	Liquid compositions comprising one or more medicaments
US8834891B2 (en)	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
US11865172B2 (en)	2005-04-21	2024-01-09	University Of Florida Research Foundation, Inc.	Materials and methods for respiratory disease control in canines
US7959929B2 (en)	2005-04-21	2011-06-14	University Of Florida Research Foundation, Inc.	Materials and methods for respiratory disease control in canines
US8398994B2 (en) *	2005-07-15	2013-03-19	Boehringer Ingelheim Vetmedica, Inc.	Lawsonia vaccine and methods of use thereof
EP1941033A2 (fr) *	2005-10-20	2008-07-09	Wyeth a Corporation of the State of Delaware	Compositions et méthodes pour traiter une virose de la grippe canine
US8052971B2 (en) *	2005-11-21	2011-11-08	MG Biologics	Oral use of specific antibodies for intestinal health
US7682619B2 (en)	2006-04-06	2010-03-23	Cornell Research Foundation, Inc.	Canine influenza virus
US8470336B2 (en) *	2006-05-25	2013-06-25	Boehringer Ingelheim Vetmedica, Inc.	Vaccination of young animals against Lawsonia intracellularis infections
JPWO2008032796A1 (ja)	2006-09-13	2010-01-28	日本全薬工業株式会社	新規イヌ用ワクチン
US7674469B2 (en) *	2006-10-25	2010-03-09	Internet International B.V.	Feline influenza vaccine and method of use
CA2674026C (fr) *	2006-12-27	2018-08-21	Pfizer Products Inc.	Procedes d'administration de vaccin
WO2009037262A2 (fr)	2007-09-17	2009-03-26	Boehringer Ingelheim Vetmedica, Inc.	Procédé de prévention des infections précoces de lawsonia intracellularis
JP5257939B2 (ja) *	2009-02-24	2013-08-07	独立行政法人農業・食品産業技術総合研究機構	豚丹毒・豚マイコプラズマ肺炎経口投与型多価ワクチン
BR112012000951A2 (pt) *	2009-07-17	2016-03-15	Univ Oklahoma State	método para imunizar um animal, formulação imunogênica, e, aplicador supralingual
US8453601B2 (en) *	2011-05-19	2013-06-04	C-Lock Inc.	Vaccine and health-related applications for ruminant breath monitoring system
US20140127352A1 (en) *	2012-11-05	2014-05-08	Nestec Sa	Flavored drinking waters and methods for improving hydration for animals
WO2014143781A1 (fr) *	2013-03-15	2014-09-18	Camas Incorporated	Procédés et compositions pour réduire des micro-organismes dans l'oropharynx, le nasopharynx et les cavités buccales
AU2016255437B2 (en)	2015-04-28	2020-10-08	Mars, Incorporated	Process of preparing a sterilized wet pet food product
US11135285B2 (en) *	2016-11-29	2021-10-05	Intervet Inc.	Swine vaccine
NL2018155B1 (en)	2017-01-11	2018-07-25	Intervet Int Bv	Oral vaccine against ruminant respiratory disease
MX2018015344A (es)	2016-12-15	2019-04-29	Nestec Sa	Composiciones y metodos que modulan las bacterias en un animal de compañía.
US20220054616A1 (en) *	2019-01-04	2022-02-24	Boehringer Ingelheim Animal Health USA Inc.	Attenuated Bordetella Bronchiseptica Strains, Oral Vaccines Containing the Attenuated Strains, and Methods of Making & Use Thereof
KR102234525B1 (ko) *	2020-08-28	2021-03-30	안병철	송아지의 점막관련 전염성 질병을 예방 또는 치료하기 위한 혈청의 제조방법, 상기 방법에 의해 제조된 혈청 및 이의 용도
US10973908B1 (en)	2020-05-14	2021-04-13	David Gordon Bermudes	Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en)	2020-07-22	2026-01-27	David Gordon Bermudes	Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins
CN115040468B (zh) *	2022-05-16	2023-02-07	中国农业科学院北京畜牧兽医研究所	一种中大体型动物口服免疫或给药“辣条”及其生产方法
FR3149494A1 (fr) *	2023-06-06	2024-12-13	Ceva Sante Animale	Méthode pour améliorer la prise d’une substance liquide ou visqueuse

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2966443A (en) *	1959-06-22	1960-12-27	American Cyanamid Co	Trivalent poliomyelitis live virus vaccine
US3224941A (en) *	1963-01-21	1965-12-21	Lilly Co Eli	Resin compositions and method for controlling diarrhea
GB1102676A (en) *	1965-10-08	1968-02-07	Hart Mfg Co H W	Apparatus for supplying water to fowls
DE1792256C3 (de) *	1968-08-10	1979-07-05	Kali-Chemie Pharma Gmbh, 3000 Hannover	Oral applizierbare, polyvalente Impfstoffe gegen lokale Darminfektionen
US4141229A (en) *	1977-10-11	1979-02-27	Stanly Knitting Mills, Inc.	Knit cap with elastic head band
US5882649A (en) *	1990-04-24	1999-03-16	Flustat Pty. Ltd.	Oral vaccine comprising antigen surface-associated with red blood cells
AU8195391A (en) *	1990-06-13	1992-01-07	Smithkline Beecham Corporation	Pasteurella multocida toxoid vaccines
US5846805A (en) *	1991-08-26	1998-12-08	Boehringer Ingelheim Animal Health, Inc.	Culture of swine infertility and respiratory syndrome virus in simian cells
US5419907A (en) *	1992-11-10	1995-05-30	Iowa State University Research Foundation, Inc.	Pathogenic porcine respiratory coronavirus
KR100304064B1 (ko) *	1993-08-12	2001-11-22	다카하시 미치나오	구강용조성물
FR2710500B1 (fr) *	1993-09-27	1995-12-01	Virbac Laboratoires	Composition et système à administration orale pour animaux, leur procédé de préparation et leurs applications.
US6019982A (en) *	1994-08-26	2000-02-01	The Administrators Of The Tulane Educational Fund	Mutant enterotoxin effective as a non-toxic oral adjuvant
US5985336A (en) *	1995-06-07	1999-11-16	Novus International, Inc.	Nutrient formulation and process for feeding young poultry and other animals
US5884583A (en) *	1997-03-28	1999-03-23	Rhone Merieux, Inc.	Field bag boost vaccination delivery system
US6100388A (en) *	1998-03-16	2000-08-08	Biogaia Biologies Ab	Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
US20020064517A1 (en) *	1998-04-30	2002-05-30	Stewart A. Cederholm-Williams	Fibrin sealant as a transfection/transformation vehicle for gene therapy
IL139538A0 (en) *	1998-05-15	2004-02-08	Mkb Invest Ltd Partnership	Compositions and method for immunizing poultry
US6399074B1 (en) *	1998-07-24	2002-06-04	Megan Health, Inc.	Live attenuated salmonella vaccines to control avian pathogens
US6713073B1 (en) *	1998-07-24	2004-03-30	Megan Health, Inc.	Method of vaccination of newly hatched poultry
US6552024B1 (en) *	1999-01-21	2003-04-22	Lavipharm Laboratories Inc.	Compositions and methods for mucosal delivery
KR100324441B1 (ko) *	1999-02-08	2002-02-27	이은선	위염, 위궤양, 십이지장궤양 예방을 위한 식품
US6225304B1 (en) *	1999-02-17	2001-05-01	Pharmaceutical Solutions, Inc.	Soluble forms of amoxicillin and treatment of animals
US7018638B2 (en) *	2000-12-19	2006-03-28	Wyeth	Mycoplasma hyopneumoniae bacterin vaccine

2001
- 2001-06-14 MY MYPI20012800A patent/MY128159A/en unknown
- 2001-06-19 AR ARP010102904A patent/AR030702A1/es unknown
- 2001-06-21 US US09/887,296 patent/US20020025325A1/en not_active Abandoned
- 2001-06-22 BR BR0111916-8A patent/BR0111916A/pt not_active IP Right Cessation
- 2001-06-22 NZ NZ523329A patent/NZ523329A/en unknown
- 2001-06-22 CZ CZ20024222A patent/CZ20024222A3/cs unknown
- 2001-06-22 HU HU0301394A patent/HUP0301394A3/hu unknown
- 2001-06-22 WO PCT/US2001/020155 patent/WO2002002139A2/fr not_active Ceased
- 2001-06-22 KR KR1020027018051A patent/KR20030013480A/ko not_active Ceased
- 2001-06-22 MX MXPA02012201A patent/MXPA02012201A/es not_active Application Discontinuation
- 2001-06-22 JP JP2002506760A patent/JP2004501979A/ja active Pending
- 2001-06-22 YU YU99102A patent/YU99102A/sh unknown
- 2001-06-22 AU AU7013501A patent/AU7013501A/xx active Pending
- 2001-06-22 PL PL36002601A patent/PL360026A1/xx not_active Application Discontinuation
- 2001-06-22 EP EP01948685A patent/EP1294399A2/fr not_active Withdrawn
- 2001-06-22 CN CNB018121500A patent/CN100457179C/zh not_active Expired - Fee Related
- 2001-06-22 AU AU2001270135A patent/AU2001270135B2/en not_active Ceased
2002
- 2002-11-18 BG BG107282A patent/BG107282A/bg unknown
- 2002-12-20 ZA ZA200210402A patent/ZA200210402B/en unknown
2005
- 2005-12-29 US US11/321,389 patent/US20060171960A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AR030702A1 (es)	2003-09-03
ZA200210402B (en)	2004-03-23
WO2002002139A3 (fr)	2002-07-04
US20020025325A1 (en)	2002-02-28
NZ523329A (en)	2005-10-28
KR20030013480A (ko)	2003-02-14
HUP0301394A2 (hu)	2003-08-28
AU2001270135B2 (en)	2005-05-26
CN1529615A (zh)	2004-09-15
PL360026A1 (en)	2004-09-06
BR0111916A (pt)	2003-05-13
JP2004501979A (ja)	2004-01-22
US20060171960A1 (en)	2006-08-03
CN100457179C (zh)	2009-02-04
MY128159A (en)	2007-01-31
CZ20024222A3 (cs)	2003-06-18
MXPA02012201A (es)	2003-06-06
EP1294399A2 (fr)	2003-03-26
YU99102A (sh)	2006-01-16
HUP0301394A3 (en)	2004-10-28
WO2002002139A2 (fr)	2002-01-10
AU7013501A (en)	2002-01-14

Publication	Publication Date	Title
BG107282A (bg)	2003-06-30	Метод и състав на ваксина за орален прием
Baskerville et al.	1973	Aujeszky's disease in pigs.
AU2001270135A1 (en)	2002-04-11	Methods and composition for oral vaccination
CA2769223C (fr)	2015-03-17	Gel mou collant pour traiter la volaille
RU2761966C2 (ru)	2021-12-14	Пероральная вакцина против респираторного заболевания жвачных животных, содержащая поливинилпирролидон
US20110129479A1 (en)	2011-06-02	Immunogen selection directed in immunoglobulin packages in plasma and colostrum and method of making and using same
Makoschey	2015	Modes of vaccine administration at a glance
RU2678132C2 (ru)	2019-01-23	Продукт для здоровья собак, содержащий антитела против собачьего парвовируса типа 2
De Jong	1987	Prevention of Atrophic Rhinitis in piglets by means of intranasal administration of a live non‐AR‐pathogenic Bordetella bronchiseptica vaccine
Palya	1991	Manual for the production of Marek's disease, Gumboro disease and inactivated Newcastle disease vaccines
Fu et al.	1989	Natural transmission of group A rotavirus within a pig population
HRP20030062A2 (en)	2003-04-30	Methods and composition for oral vaccination
AU2005203441A1 (en)	2005-08-25	Methods and composition for oral vaccination
Van Dreumel et al.	1969	A common source epizootic of bovine salmonellosis in Manitoba
ES2371395T3 (es)	2011-12-30	Inhibidor de adherencia de inmunógenos y procedimiento de preparación y uso del mismo.
Jones et al.	1961	Microbiological aspects of Listeria monocytogenes with special reference to listeriosis in animals.
Agayeva et al.	2025	Study of Diagnostic Methods and Control Measures For Listerosis Disease Among Big-Horned Animals in the Ganja-Gazakh Zone
Danields et al.	1993	Beef cattle salmonellosis: a study of oral S. typhimurium and topical S. newport inoculations
Doyle	1960	Can swine erysipelas be eradicated? Epidemiological and immunological aspects.
AU4078699A (en)	1999-12-06	Compositions and method for immunizing poultry
US6517844B1 (en)	2003-02-11	Compositions and method for immunizing polutry
PFÜTZNER et al.	0	YkS eegg gAAAS
Bain	1986	Aspects of Immunisation of Calves Against Dictyocaulus viviparus
Sahu	1984	B) Related Syndromes. Venereal diseases caused by Klebsiella pneumonia
Farley	1934	Studies on shipping fever